Safety and efficacy of nabumetone in osteoarthritis: Emphasis on gastrointestinal safety

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 4, 2000, Pages 443-452

  Scott, D L ^a   Palmer, R H ^b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c SmithKline Beecham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; HEMOGLOBIN; NABUMETONE; PIROXICAM;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXITIS; DIARRHEA; DIGESTIVE SYSTEM ULCER; DIVERTICULITIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FEMALE; FLATULENCE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; KNEE OSTEOARTHRITIS; MALE; MULTICENTER STUDY; NAUSEA; OCCULT BLOOD; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; SIDE EFFECT; ULCER PERFORATION; VOMITING;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTANONES; DIGESTIVE SYSTEM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE;

EID: 0034115621     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00715.x     Document Type: Article

References (32)

1. 1 Paulus HE. FDA arthritis advisory committee meeting: serious gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs, etc. Arthritis Rheum 1988; 31: 1450-1.
2. 2 Larkai EN, Smith JL, Lidsky MD, Sessoms SL, Graham DY. Dyspepsia in NSAID users: the size of the problem. J Clin Gastroenterol 1989; 11: 158-62.
3. 3 Price AH, Fletcher M. Mechanisms of NSAID-induced gastroenteropathy. Drugs 1990; 40(Suppl. 5): 1-11.
4. 4 Fries J. Nonsteroidal anti-inflammatory drug safety: a view from the ARAMIS data bank. Curr Opinion Rheumatol 1996; 8(Suppl. 1): S3-7.
5. 5 Bjorkman D. Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus. Am J Med 1998; 105: S17-21.
6. 6 Peura DA, Lanza FL, Gostout CJ, Foutch PG. The American College of Gastroenterology bleeding registry: Preliminary findings. Am J Gastroenterol 1997; 92: 924-8.
7. 7 Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992; 103: 862-9.
8. 8 Wilcox CM, Alexander LN, Cotsonis GA, Clark WS. Nonsteroidal anti-inflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997; 42: 990-7.
9. 9 Holt S, Rigoglioso V, Sidhu M, et al. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal bleeding. Dig Dis Sci 1993; 38: 1619-23.
10. 10 Fleischmann RM. Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis. J Rheumatol 1992; 19(Suppl. 36): 32-40.
11. 11 Jackson RE, Mitchell FN, Brindley DA. Safety evaluation of nabumetone in United States clinical trials. Am J Med 1987; 83(Suppl. 4B): 115-20.
12. 12 Eversmeyer W, Poland M, DeLapp RE, Jensen CP. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. Am J Med 1993; 95(Suppl. 2A): S10-18.
13. 13 Morgan GJ, Poland M, DeLapp R. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly. Am J Med 1993; 95(Suppl. 2A): S19-27.
14. 14 Bernhard GC. Worldwide safety experience with nabumetone. J Rheumatol 1992; 19(Suppl. 36): 48-57.
15. 15 Lipani JA, Poland M. Clinical update of the relative safety of nabumetone in long-term clinical trials. Inflammopharmacology 1995; 3: 351-61.
16. 16 Singh G, Terry R, Ramey DR, Fries JF, Triadafilopoulos Halpern J, Brown BW. Comparative toxicity of NSAIDs. Arthritis Rheum 1997; 40(Suppl. 9): S115.
17. 17 MacDonald TM, Morant SV, Robinson GC, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. Br Med J 1997; 315: 1333-7.
18. 18 Nunn B, Chamberlain PD. Effect of nabumetone (BRL 14777), a new anti-inflammatory drug, on human platelet reactivity ex vivo: comparison with naproxen. J Pharm Pharmacol 1982; 34: 576-9.
19. 19 Freed MI, Audet PR, Zariffa N, et al. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers. J Clin Pharmacol 1994; 34: 1098-108.
20. 20 Al Balla S, Al Momen AK, Al Arfaj H, Al Sugair S, Gader AMA. Interaction between nabumetone - a new non-steroidal anti-inflammatory - and the haemostatic system ex vivo. Haemostasis 1990; 20: 270-5.
21. 21 Schnitzer TJ, Donahue JR, Toomey EP, et al. Effect of nabumetone on hemostasis during arthroscopic knee surgery. Clin Ther 1998; 20: 110-24.
22. 22 Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957; 16: 494-502.
23. 23 Bellamy N, Bensen WG, Beaulieu A, et al. A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis. J Rheumatol 1995; 22: 915-20.
24. 24 Laws D, Saul S, Fehilly B. A microcomputer-assisted study of nabumetone and slow release diclofenac SR in osteoarthritis. Drugs 1990; 40(Suppl. 5): 29-33.
25. 25 Rees T, Scott M, Saul S, Kill D, Fehilly B. A multicentre general practice trial of nabumetone and slow-release diclofenac in osteoarthritis. Drug Invest 1990; 2: 53-60.
26. 26 Lister BJ, Poland M, DeLapp RE. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. Am J Med 1993; 95(Suppl. 2A): S2-9.
27. 27 De Bock GH, Hermans J, Mulder JD. Randomized double-blind study of nabumetone and piroxicam in the treatment of osteoarthritis in Dutch general practice: efficacy and tolerability. Pharm World Sci 1993; 15: 132-8.
28. 28 Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 1991; 18: 6-10.
29. 29 Rodriguez LAG. Nonsteroidal anti-inflammatory drugs, ulcers and risk: a collaborative meta-analysis. Semin Arthritis Rheum 1997; 26: 16-20.
30. 30 Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-63.
31. 31 Francis JL, Dawwes RFH, Roath OS. The effect of diclofenac on platelet aggregation and post-operative bleeding. Hematol Rev 1988; 2: 283-91.
32. 32 DiPerri T, Pasini L, Auteri A, Vittoria A, Messa GL. Effect of single dose of piroxicam on human platelet aggregation in vivo. Int J Tiss React 1979; 1: 161-2.